Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 4, 2010, Pages 598-605

  Kreymborg, Karsten grosse ^a,b,c   Uchida, Shizuka ^b   Gellert, Pascal ^b   Schneider, André ^b   Boettger, Thomas ^b   Voswinckel, Robert ^a,b   Wietelmann, Astrid ^b   Szibor, Marten ^b   Weissmann, Norbert ^a   Ghofrani, Ardeschir Hossein ^a   Schermuly, Ralph ^a,b   Schranz, Dietmar ^c   Seeger, Werner ^a,b   Braun, Thomas ^b  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cardiac remodeling; Congenital heart disease; Microarray; Pulmonary hypertension; Right ventricle

Indexed keywords

ACTIN BINDING PROTEIN; ACTIN BINDING RHO ACTIVATING PROTEIN; ANKYRIN; ANKYRIN REPEAT DOMAIN 23; BETA TUBULIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN B2; DOPACHROME TAUTOMERASE; HOMEODOMAIN PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR LIKE 1; MESENCHYME HOMEOBOX 1; MYOSIN BINDING PROTEIN C; OSTEONECTIN; PROCOLLAGEN; PROCOLLAGEN TYPE 4 ALPHA 1; PROCOLLAGEN TYPE 8 ALPHA 1; PROTEIN CILP; PROTEIN SORCS2; RECEPTOR PROTEIN; REGULATOR OF CALCINEURIN 1; REGULATOR PROTEIN; SCLEROPROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; GENE ACTIVITY; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE HYPERTROPHY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; CLUSTER ANALYSIS; HYPERTROPHY, RIGHT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VENTRICULAR OUTFLOW OBSTRUCTION;

MURINAE; MUS;

EID: 77956180067     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.07.014     Document Type: Article

References (36)

1. Frey N., Katus H.A., Olson E.N., Hill J.A. Hypertrophy of the heart: a new therapeutic target?. Circulation 2004, 109(13):1580-1589.
2. Voelkel N.F., Quaife R.A., Leinwand L.A., Barst R.J., McGoon M.D., Meldrum D.R., et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006, 114(17):1883-1891.
3. Greyson C.R. Pathophysiology of right ventricular failure. Crit Care Med 2008, 36(1 Suppl):S57-S65.
4. Rutledge J.M., Nihill M.R., Fraser C.D., Smith O.E., McMahon C.J., Bezold L.I. Outcome of 121 patients with congenitally corrected transposition of the great arteries. Pediatr Cardiol 2002, 23(2):137-145.
5. Rockman H.A., Ono S., Ross R.S., Jones L.R., Karimi M., Bhargava V., et al. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci USA 1994, 91(7):2694-2698.
6. Gautier L., Cope L., Bolstad B.M., Irizarry R.A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20(3):307-315.
7. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3(1). [Article 3].
8. Ihaka R., Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat 1996, 5:299-314.
9. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31(4):e15.
10. PGA. Genomics of Cardiovascular Development, Adaptation, and Remodeling. NHLBI Program for Genomic Applications, Harvard Medical School ( - January 2, 2008). http://www.cardiogenomics.org.
11. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95(25):14863-14868.
12. Eisen Lab Software []. http://rana.lbl.gov/EisenSoftware.htm.
13. Uchida S., Nishida Y., Satou K., Muta S., Tashiro K., Kuhara S. Detection and normalization of biases present in spotted cDNA microarray data: a composite method addressing dye, intensity-dependent, spatially-dependent, and print-order biases. DNA Res 2005, 12(1):1-7.
14. Ryan T., Petrovic O., Dillon J.C., Feigenbaum H., Conley M.J., Armstrong W.F. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol 1985, 5(4):918-927.
15. Urashima T., Zhao M., Wagner R., Fajardo G., Farahani S., Quertermous T., et al. Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circ Physiol 2008, 295(3):H1351-H1368.
16. Mirotsou M., Dzau V.J., Pratt R.E., Weinberg E.O. Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy. Physiol Genomics 2006, 27(1):86-94.
17. Bogaard H.J., Abe K., Vonk Noordegraaf A., Voelkel N.F. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009, 135(3):794-804.
18. Tabibiazar R., Wagner R.A., Liao A., Quertermous T. Transcriptional profiling of the heart reveals chamber-specific gene expression patterns. Circ Res 2003, 93(12):1193-1201.
19. Seki S., Kawaguchi Y., Chiba K., Mikami Y., Kizawa H., Oya T., et al. A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease. Nat Genet 2005, 37(6):607-612.
20. Hayes C.J., Gersony W.M., Driscoll D.J., Keane J.F., Kidd L., O'Fallon W.M., et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation 1993, 87(2 Suppl):I28-I37.
21. Rhodes J., Dave A., Pulling M.C., Geggel R.L., Marx G.R., Fulton D.R., et al. Effect of pulmonary artery stenoses on the cardiopulmonary response to exercise following repair of tetralogy of Fallot. Am J Cardiol 1998, 81(10):1217-1219.
22. Belenkie I., Smith E.R., Tyberg J.V. Ventricular interaction: from bench to bedside. Ann Med 2001, 33(4):236-241.
23. Fagan K.A., Oka M., Bauer N.R., Gebb S.A., Ivy D.D., Morris K.G., et al. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 2004, 287(4):L656-L664.
24. Taraseviciene-Stewart L., Kasahara Y., Alger L., Hirth P., Mc Mahon G., Waltenberger J., et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001, 15(2):427-438.
25. Werchan P.M., Summer W.R., Gerdes A.M., McDonough K.H. Right ventricular performance after monocrotaline-induced pulmonary hypertension. Am J Physiol 1989, 256(5 Pt 2):H1328-H1336.
26. Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003, 5(6):877-889.
27. Levy D., Larson M.G., Benjamin E.J., Newton-Cheh C., Wang T.J., Hwang S.J., et al. Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007, 8(Suppl 1):S3.
28. Gould D.B., Phalan F.C., van Mil S.E., Sundberg J.P., Vahedi K., Massin P., et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006, 354(14):1489-1496.
29. Brancaccio M., Hirsch E., Notte A., Selvetella G., Lembo G., Tarone G. Integrin signaling: the tug-of-war in heart hypertrophy. Cardiovasc Res 2006, 70(3):422-433.
30. Unterseher F., Hefele J.A., Giehl K., De Robertis E.M., Wedlich D., Schambony A. Paraxial protocadherin coordinates cell polarity during convergent extension via Rho A and JNK. EMBO J 2004, 23(16):3259-3269.
31. Bereczki E., Santha M. The role of biglycan in the heart. Connect Tissue Res 2008, 49(3):129-132.
32. Liu Q., Yu L., Gao J., Fu Q., Zhang J., Zhang P., et al. Cloning, tissue expression pattern and genomic organization of latexin, a human homologue of rat carboxypeptidase A inhibitor. Mol Biol Rep 2000, 27(4):241-246.
33. Garabelli P.J., Modrall J.G., Penninger J.M., Ferrario C.M., Chappell M.C. Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart. Exp Physiol 2008, 93(5):613-621.
34. Wilkins B.J., Dai Y.S., Bueno O.F., Parsons S.A., Xu J., Plank D.M., et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 2004, 94(1):110-118.
35. Harris C.D., Ermak G., Davies K.J. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci 2005, 62(21):2477-2486.
36. Mori M., Nakajima M., Mikami Y., Seki S., Takigawa M., Kubo T., et al. Transcriptional regulation of the cartilage intermediate layer protein (CILP) gene. Biochem Biophys Res Commun 2006, 341(1):121-127.